Evolve Private Wealth’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$260K Buy
+8,483
New +$190K 0.01% 751

Other funds holding CAI

Evolve Private Wealth's CAI Position: Q3 2026 in Review

Evolve Private Wealth opened a new position in Caris Life Sciences (CAI) in Q3 2026: 8,483 shares worth $260K. The stake represents 0.01% of the portfolio and ranks #751 among its holdings.

326 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • Evolve Private Wealth held 8,483 shares of Caris Life Sciences worth $260K as of Q3 2026.
  • Caris Life Sciences was a new Evolve Private Wealth position in Q3 2026.
  • Caris Life Sciences made up 0.01% of Evolve Private Wealth's portfolio in Q3 2026, its #751 holding.
  • 326 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Evolve Private Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.